Merck’s Keytruda holds on to the top spot while AbbVie’s Humira—once the world’s top-selling drug—continues to cede its ...

Pharmacy benefit managers take considerably different approaches to managing patient access to biosimilars, or cheaper ...

The Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for depemokimab for asthma with type 2 inflammation and chronic rhinosinusitis with nasal polyps ...

The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing ...

Jazz Pharmaceuticals said Wednesday it would spend nearly $1 billion to buy Chimerix and its experimental pill for a ...

If you’re looking for cordless audio, this is the list you need—from affordable in-ear options to premium earphones, we’ve ranked the best wireless earbuds available right now. Whether you’re tired of ...

The medical sector is usually of interest during economic uncertainty, especially when it leads to heightened stock market volatility. With investors feeling the jitters from tariff concerns and ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amneal ...